Saturn V Capital Management LP Diversified Active

Name: Saturn V Capital Management LP Q1 2026 13F Filing | 13F Explorer
Creator: Saturn V Capital Management LP
Published: 2026-05-15

Location: AUSTIN, TX

CIK: 0001964437 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $552M (100.0% shares, 0.0% debt)

Holdings (21)

New Positions (4)

CADL CANDEL THERAPEUTICS INC 2.6%

Value $14.19M Shares 2,896,588 Est. Cost — Unrealized —

ZURA ZURA BIO LTD 0.8%

Value $4.403M Shares 739,960 Est. Cost — Unrealized —

ANRO ALTO NEUROSCIENCE INC 0.4%

Value $2.001M Shares 88,999 Est. Cost — Unrealized —

MSLE SATELLOS BIOSCIENCE INC 0.4%

Value $1.97M Shares 350,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CADL	CANDEL THERAPEUTICS INC	2,896,588	$14.19M	2.6%	—	—	COM	137404109
ZURA	ZURA BIO LTD	739,960	$4.403M	0.8%	—	—	CLASS A ORD SHS	G9TY5A101
ANRO	ALTO NEUROSCIENCE INC	88,999	$2.001M	0.4%	—	—	COM SHS	02157Q109
MSLE	SATELLOS BIOSCIENCE INC	350,000	$1.97M	0.4%	—	—	COM	80401L803

Increased Positions (9)

ALMS ALUMIS INC 12.8%

Value $70.54M (+130.5%) Shares 3,202,075 (+2.1%) Est. Cost — Unrealized —

IMMX IMMIX BIOPHARMA INC 6.1%

Value $33.65M (+114.5%) Shares 3,693,585 (+23.2%) Est. Cost — Unrealized —

PCVX VAXCYTE INC 8.7%

Value $47.91M (+30.0%) Shares 824,532 (+3.2%) Est. Cost — Unrealized —

OVID OVID THERAPEUTICS INC 1.7%

Value $9.25M (+127.0%) Shares 4,166,666 (+66.7%) Est. Cost — Unrealized —

IRON DISC MEDICINE INC 5.2%

Value $28.77M (+21.4%) Shares 449,926 (+50.8%) Est. Cost — Unrealized —

IVVD INVIVYD INC 2.6%

Value $14.23M (-25.5%) Shares 10,949,084 (+41.5%) Est. Cost — Unrealized —

XFOR X4 PHARMACEUTICALS INC 4.8%

Value $26.67M (+14.9%) Shares 6,456,646 (+11.3%) Est. Cost — Unrealized —

MNPR MONOPAR THERAPEUTICS INC 3.4%

Value $18.94M (-11.0%) Shares 345,626 (+6.1%) Est. Cost — Unrealized —

PHVS PHARVARIS N V 6.1%

Value $33.94M (+7.3%) Shares 1,201,402 (+5.4%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALMS	ALUMIS INC	3,202,075 (+2.1%)	$70.54M (+130.5%)	12.8%	—	—	COM	022307102
IMMX	IMMIX BIOPHARMA INC	3,693,585 (+23.2%)	$33.65M (+114.5%)	6.1%	—	—	COM	45258H106
PCVX	VAXCYTE INC	824,532 (+3.2%)	$47.91M (+30.0%)	8.7%	—	—	COM	92243G108
OVID	OVID THERAPEUTICS INC	4,166,666 (+66.7%)	$9.25M (+127.0%)	1.7%	—	—	COM	690469101
IRON	DISC MEDICINE INC	449,926 (+50.8%)	$28.77M (+21.4%)	5.2%	—	—	COM	254604101
IVVD	INVIVYD INC	10,949,084 (+41.5%)	$14.23M (-25.5%)	2.6%	—	—	COM	00534A102
XFOR	X4 PHARMACEUTICALS INC	6,456,646 (+11.3%)	$26.67M (+14.9%)	4.8%	—	—	COM NEW	98420X202
MNPR	MONOPAR THERAPEUTICS INC	345,626 (+6.1%)	$18.94M (-11.0%)	3.4%	—	—	COM NEW	61023L207
PHVS	PHARVARIS N V	1,201,402 (+5.4%)	$33.94M (+7.3%)	6.1%	—	—	COM	N69605108

Exited Positions (3)

OCUL OCULAR THERAPEUTIX INC 3.3%

Value $18.27M Shares 1,504,880 Est. Cost — Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 1.3%

Value $7.07M Shares 282,692 Est. Cost — Unrealized —

IVA INVENTIVA SA 0.2%

Value $1.317M Shares 283,166 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
OCUL	OCULAR THERAPEUTIX INC	1,504,880	$18.27M	3.3%	—	—	—	67576A100
CNTA	CENTESSA PHARMACEUTICALS PLC	282,692	$7.07M	1.3%	—	—	—	152309100
IVA	INVENTIVA SA	283,166	$1.317M	0.2%	—	—	—	46124U107

Decreased Positions (6)

ABVX ABIVAX SA 10.9%

Value $60.43M (-31.0%) Shares 542,696 (-16.4%) Est. Cost — Unrealized —

COGT COGENT BIOSCIENCES INC 4.4%

Value $24.12M (-44.2%) Shares 626,635 (-48.5%) Est. Cost — Unrealized —

DYN DYNE THERAPEUTICS INC 3.2%

Value $17.52M (-49.9%) Shares 966,609 (-46.0%) Est. Cost — Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 5.6%

Value $30.81M (-26.9%) Shares 162,961 (-34.3%) Est. Cost — Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 10.9%

Value $60.46M (+11.3%) Shares 4,349,885 (-3.3%) Est. Cost — Unrealized —

CELC CELCUITY INC 5.8%

Value $32.18M (+1.7%) Shares 281,904 (-11.1%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ABVX	ABIVAX SA	542,696 (-16.4%)	$60.43M (-31.0%)	10.9%	—	—	SPONSORED ADS	00370M103
COGT	COGENT BIOSCIENCES INC	626,635 (-48.5%)	$24.12M (-44.2%)	4.4%	—	—	COM	19240Q201
DYN	DYNE THERAPEUTICS INC	966,609 (-46.0%)	$17.52M (-49.9%)	3.2%	—	—	COM	26818M108
JAZZ	JAZZ PHARMACEUTICALS PLC	162,961 (-34.3%)	$30.81M (-26.9%)	5.6%	—	—	SHS USD	G50871105
AMLX	AMYLYX PHARMACEUTICALS INC	4,349,885 (-3.3%)	$60.46M (+11.3%)	10.9%	—	—	COM	03237H101
CELC	CELCUITY INC	281,904 (-11.1%)	$32.18M (+1.7%)	5.8%	—	—	COM	15102K100

Unchanged Positions (2)

OCS OCULIS HOLDING AG 2.5%

Value $13.74M Shares 516,761 Est. Cost — Unrealized —

IKT INHIBIKASE THERAPEUTICS INC 1.2%

Value $6.491M Shares 3,863,445 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
OCS	OCULIS HOLDING AG	516,761	$13.74M	2.5%	—	—	ORDINARY SHARES	H5870P102
IKT	INHIBIKASE THERAPEUTICS INC	3,863,445	$6.491M	1.2%	—	—	COM NEW	45719W205